Literature DB >> 14557028

What is driving the acquisition of mutS and rpoS polymorphisms in Escherichia coli?

Thomas Ferenci1.   

Abstract

Pathogenic and commensal Escherichia coli isolates frequently contain defective alleles of the mutS and rpoS genes, located in a highly polymorphic segment of the chromosome. The environments leading to enrichment of rpoS mutations and the selective advantages of these mutants are becoming apparent. Unexpectedly, rpoS defects occur because of a basic design limitation in cellular regulation. Antagonistic pleiotropy results from the futile competition between different sigma factors associated with the RNA polymerase, and drives the elimination of RpoS (or sigma(S)) in environments requiring high levels of transcription that is dependent on RpoD (or sigma(D) or sigma(70)). Nutrient-limited environments provide an ideal breeding ground for rpoS mutations. By contrast, in other settings, increased stress resistance selects for restoration of rpoS function. Hence extensive polymorphism in the mutS-rpoS region is postulated to result from cycling between environments in which the functional or non-functional genes provide distinct fitness advantages.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557028     DOI: 10.1016/j.tim.2003.08.003

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  44 in total

1.  A regulatory trade-off as a source of strain variation in the species Escherichia coli.

Authors:  Thea King; Akira Ishihama; Ayako Kori; Thomas Ferenci
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

2.  Multiple transcription-activating sequences regulate the RsmZ regulatory small RNA of Pseudomonas brassicacearum.

Authors:  D Lalaouna; S Fochesato; M Barakat; P Ortet; W Achouak
Journal:  J Bacteriol       Date:  2012-07-06       Impact factor: 3.490

3.  Genotype-by-environment interactions influencing the emergence of rpoS mutations in Escherichia coli populations.

Authors:  Thea King; Shona Seeto; Thomas Ferenci
Journal:  Genetics       Date:  2006-02-19       Impact factor: 4.562

4.  The elusive object of desire--interactions of bacteriophages and their hosts.

Authors:  Sergei Nechaev; Konstantin Severinov
Journal:  Curr Opin Microbiol       Date:  2008-04-08       Impact factor: 7.934

5.  The rpoS gene is predominantly inactivated during laboratory storage and undergoes source-sink evolution in Escherichia coli species.

Authors:  Alexandre Bleibtreu; Olivier Clermont; Pierre Darlu; Jérémy Glodt; Catherine Branger; Bertrand Picard; Erick Denamur
Journal:  J Bacteriol       Date:  2014-09-29       Impact factor: 3.490

6.  Inactivation of Transcriptional Regulators during Within-Household Evolution of Escherichia coli.

Authors:  Dagmara I Kisiela; Matthew Radey; Sandip Paul; Stephen Porter; Kseniya Polukhina; Veronika Tchesnokova; Sofiya Shevchenko; Diana Chan; Maliha Aziz; Timothy J Johnson; Lance B Price; James R Johnson; Evgeni V Sokurenko
Journal:  J Bacteriol       Date:  2017-06-13       Impact factor: 3.490

Review 7.  The functional basis of adaptive evolution in chemostats.

Authors:  David Gresham; Jungeui Hong
Journal:  FEMS Microbiol Rev       Date:  2014-12-04       Impact factor: 16.408

8.  Role of RpoS in the virulence of Citrobacter rodentium.

Authors:  Tao Dong; Brian K Coombes; Herb E Schellhorn
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

9.  Transcription analysis of central metabolism genes in Escherichia coli. Possible roles of sigma38 in their expression, as a response to carbon limitation.

Authors:  Leticia Olvera; Alfredo Mendoza-Vargas; Noemí Flores; Maricela Olvera; Juan Carlos Sigala; Guillermo Gosset; Enrique Morett; Francisco Bolívar
Journal:  PLoS One       Date:  2009-10-19       Impact factor: 3.240

10.  E Unibus Plurum: genomic analysis of an experimentally evolved polymorphism in Escherichia coli.

Authors:  Margie A Kinnersley; William E Holben; Frank Rosenzweig
Journal:  PLoS Genet       Date:  2009-11-06       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.